Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
|Articles|June 24, 2013
- June 2013
- Volume 17
- Issue 1
Weight Loss Reduces Severity of Psoriasis
Advertisement
Weight loss may help relieve psoriasis symptoms in obese patients, according to a study published online on May 29, 2013, by JAMA Dermatology. Sixty obese patients diagnosed with psoriasis were either restricted to a low calorie diet for 16 weeks or were instructed to eat healthy foods. Patients in the low calorie group improved their Psoriasis Area and Severity Index and Dermatology Life Quality Index scores.
Articles in this issue
over 13 years ago
Pain Control: Using Nonprescription Analgesicsover 13 years ago
US-Born Children Have More Asthma, Allergies Than Immigrant Peersover 13 years ago
Finding Effective Relief for Constipationover 13 years ago
Multiple Factors Linked to Readmission After GI Surgeryover 13 years ago
Case Studies in Self-Careover 13 years ago
Multivitamin/Multimineral Supplement Useover 13 years ago
Acetaminophen Helps Death Fearsover 13 years ago
2012-2013 The Medical Year in Reviewover 13 years ago
Pharmacy Times: Leading the Wayover 13 years ago
Activity Helps Hot Flashes & Night SweatsAdvertisement
Related to this article
The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Two recent graduates share strategies for standing out in the competitive fellowship application process.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
This quiz was created in collaboration with PTCE™.
Pharmacy professionals can leverage LinkedIn to build a professional brand, expand meaningful connections, share expertise, and create opportunities for career growth.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
Oncology Pharmacists Reduce Adverse Drug Reactions in Hematologic Cancer Care
4
Recap: Tirzepatide Is Approved to Cut Cardiovascular Risk in Type 2 Diabetes
5